01
Opportunity

The Opportunity

Africa's healthcare supply chain is broken. CSP is the sovereign consolidation layer.

Africa imports over 90% of its medical devices. The supply chain between manufacturer and point of care involves 3-5 intermediaries, each adding cost, delay, and provenance risk. Government procurement cycles take 6-18 months. Manufacturer payment delays run 90-180 days. The result: patients wait, manufacturers avoid the market, and intermediaries extract value.

CSP eliminates this entire chain with a single sovereign node — principal buyer authority, AI-powered matching, embedded compliance, and direct manufacturer relationships. Specification to supply in hours, not months.

$259B+
Africa Health Market
90%+
Devices Imported
3-5
Intermediaries (avg)
6-18mo
Procurement Cycle
02
Revenue Model

Business Model

CSP operates as a principal buyer with the Triple-20-60 revenue structure.

Principal Margin

CSP purchases as principal and resells to institutional buyers. Margin embedded in procurement spread.

Platform Fees

1.5% average network fee on transaction volume flowing through the sovereign node.

Settlement Revenue

Smart contract settlement services. Manufacturers pay for instant liquidity vs. 90-180 day cycles.

03
Proof Points

Traction

$2.07M
Uganda Pilot
22
Active Markets
300+
Manufacturers
$3M
Founder Invested
04
Series A

The Ask

Series A: $5M at $20M pre-money valuation.

CSP is raising $5M in Series A capital at a $20M pre-money valuation. Founder Chris Prinsloo has invested $3M of personal capital (Project Emirates Rail) across technology co-development ($1.2M), supply chain activation ($800K), UAE positioning ($600K), and Africa pilots ($400K).

Post-investment cap table: Founder 75% / Investor 25%. Phase 1 total capitalisation: $8M ($3M founder + $5M new capital).

05
FAQ

Investor FAQ

Why not a distributor?

Distributors don't own authority. CSP purchases as principal — full manufacturer authority, clinical traceability, regulatory integrity.

How does AI matching work?

Clinical specifications are parsed and matched against 300+ manufacturer catalogues. 93% accuracy. Hours, not months.

How is compliance ensured?

FCPA, OFAC, WHO GDP embedded operationally. Not a compliance layer — built into every transaction.

What about product diversion?

Full provenance from production lot to delivery point. AfricaHealth Trust provides independent monitoring. Zero grey market risk.

Request Access

Full financial model, cap table, and governance documents available in the investor dataroom.

Financial Model Governance